Loading...

GALT GALECTIN THERAPEUTICS INC Capital Structure Changes 8-K Filing

GLCT

GLT

GALECTIN THERAPEUTICS INC

(GALT)

2025 8-K

Financial Results

Board Appointment

Retention Bonuses Approved

Director Resignation

Credit Agreement Details

Annual Meeting Results

Annual Meeting Update

Financial Update

Trial Results Announcement

Corporate Update

Financial Update

Compensatory Arrangements o...

Financial Statements

Investor Meetings

Financial Results

Corporate Presentation

Press Release Issued

Annual Meeting Results

Stockholder Meeting

Corporate Presentation

Press Release Issued

Corporate Presentation

Financial Results

Corporate Presentation

Financial Results

Promotion of Dr. Khurram Jamil

Financial Results

Earnings Reports

Annual Meeting of Stockholders

Financial Results

Financial Results Announcement

Earnings Report

Financial Results

Financial Results Announcement

External Links:

On December 19, 2025, Galectin Therapeutics Inc. entered into a $10 million line of credit agreement with Richard E. Uihlein, which includes options for convertible promissory notes and warrants for stock purchase.

AI Assistant

GALECTIN THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.